Marc Kolkman
Genencor
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marc Kolkman.
Applied and Environmental Microbiology | 2008
Marc Kolkman; René van der Ploeg; Michael Bertels; Maurits van Dijk; Joop van der Laan; Jan Maarten van Dijl; Eugenio Ferrari
ABSTRACT Proteins that are produced for commercial purposes in Bacillus subtilis are commonly secreted via the Sec pathway. Despite its high secretion capacity, the secretion of heterologous proteins via the Sec pathway is often unsuccessful. Alternative secretion routes, like the Tat pathway, are therefore of interest. Two parallel Tat pathways with distinct specificities have previously been discovered in B. subtilis. To explore the application potential of these Tat pathways, several commercially relevant or heterologous model proteins were fused to the signal peptides of the known B. subtilis Tat substrates YwbN and PhoD. Remarkably, the YwbN signal peptide directed secretion of active subtilisin, a typical Sec substrate, via the B. subtilis TatAyCy route. In contrast, the same signal peptide directed Tat-independent secretion of the Bacillus licheniformis α-amylase (AmyL). Moreover, the YwbN signal peptide directed secretion of SufI, an Escherichia coli Tat substrate, in a Tat-independent manner, most likely via Sec. Our results suggest that cytoplasmic protein folding prior to translocation is probably a major determinant of Tat-dependent protein secretion in B. subtilis, as is the case with E. coli. We conclude that future applications for the Tat system of B. subtilis will most likely involve commercially interesting proteins that are Sec incompatible.
Carbohydrate Polymers | 2018
Slavko Kralj; Chris Leeflang; Estefanía Ibáñez Sierra; Błażej Kempiński; Veli Alkan; Marc Kolkman
Fructooligosaccharides (FOS) and inulin, composed of β-2-1 linked fructose units, have a broad range of industrial applications. They are known to have various beneficial health effects and therefore have broad application potential in nutrition. For (modified) inulin also for non-food purposes more applications are arising. Examples are carboxymethylated inulin as anti-scalant and carboymlated inulin as emulsifiers. Various plants synthesize FOS and/or inulin type of fructans. However, isolating of FOS and inulin from plants is challenging due to for instance varying chains length. There is an increasing demand for FOS and inulin oligosaccharides and alternative procedures for their synthesis are attractive. We identified and characterized two fructosyltransferases from Bacillus agaradhaerens WDG185. FosA, a β-fructofuranosidase, synthesises short chain fructooligosaccharides (GF2-GF4) at high sucrose concentration, whereas InuO, an inulosucrase, synthesises a broad range of inulooligosaccharides (GF2-GF24) from sucrose, very similar to plant derived inulin. FosA and InuO showed activity over a broad pH range from 6 to 10 and optimal temperature at 60°C. Calcium ions and EDTA were found to have no effect on the activity of both enzymes. Kinetic analysis showed that only at relatively low substrate concentrations both enzymes showed Michaelis-Menten type of kinetics for total and transglycosylation activity. Both enzymes showed increased transglycosylation upon increasing substrate concentrations. These are the first examples of the molecular and biochemical characterization of a β-fructofuranosidase (FosA) and an inulosucrase enzyme (InuO) and its product from a Bacillus agaradhaerens strain.
Acta Crystallographica Section F-structural Biology and Crystallization Communications | 2007
Andrew Shaw; Mae Saldajeno; Marc Kolkman; Brian E. Jones; Richard R. Bott
The crystal structure of a secreted chymotrypsin from the alkaliphile Cellulomonas bogoriensis has been determined using data to 1.78 A resolution and refined to a crystallographic R factor of 0.167. The crystal structure reveals a large P1 substrate-specificity pocket, as expected for chymotrypsins. The structure is compared with close structural homologues. This comparison does not reveal clear reasons for the alkali tolerance of the enzyme, but the greater compactness of the structure and lowered hydrogen bonding may play a role.
Archive | 2004
Brian E. Jones; Marc Kolkman; Chris Leeflang; Hiroshi Oh; Ayrookaran J. Poulose; Eugene S. Sadlowski; Andrew Shaw; Der Kleij Wilhelmus A. H. Van; Marrewijk Leo Van
Archive | 2005
Eugenio Ferrari; Marc Kolkman; Craig E. Pilgrim
Archive | 2008
Claudine Chang; Clement Choy; Melodie Estabrook; Mansi Goyal; Thomas P. Graycar; Victoria Huang; Brian E. Jones; Marc Kolkman; Karsten Matthias Kragh; Chris Leeflang; Scott D. Power; Sandra W. Ramer; Andrew Shaw; Casper Vroemen; Walter Weyler
Archive | 2006
Katherine D. Collier; Anthony G. Day; Nobel Hans De; David A. Estell; Grant Ganshaw; Marc Kolkman; Raj Lad; Jeffrey V. Miller; Christopher J. Murray; Scott D. Power; Brian Schmidt; Kimmenade Anita Van; Gudrun Vogtentanz
Proteomics | 2006
Geeske Zanen; Haike Antelmann; Rob Meima; Jan D. H. Jongbloed; Marc Kolkman; Michael Hecker; Jan Maarten van Dijl; Wim J. Quax
Archive | 2010
David A. Estell; Brian E. Jones; Marc Kolkman; Christian D. Adams; Edward M. Concar
Microbiology | 2002
Saskia van Selm; Marc Kolkman; Bernard A.M. van der Zeijst; Kornelisje A. Zwaagstra; Wim Gaastra; Jos P. M. van Putten